Armistice Capital, Llc Alimera Sciences Inc (ALIM) insider trading activity

Armistice Capital, LLC is > 10% Shareholder of ALIMERA SCIENCES INC. Currently has a direct ownership of 6.94 Million shares of ALIM, which is worth approximately $38.4 Million. The most recent transaction as insider was on Feb 06, 2018, when has been sold 8,000 shares (Common Stock) at a price of $1.12 per share, resulting in proceeds of $8,960. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.94M

0% 3M change

0% 12M change

Total Value Held $38.4 Million

ARMISTICE CAPITAL, LLC Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 06 2018	BUY Open market or private purchase	$8,960 $1.12 p/Share	8,000 Added 0.12%	6,936,000 Common Stock
Feb 05 2018	BUY Open market or private purchase	$4,560 $1.14 p/Share	4,000 Added 0.06%	6,928,000 Common Stock
Feb 02 2018	BUY Open market or private purchase	$9,280 $1.16 p/Share	8,000 Added 0.12%	6,924,000 Common Stock

Also insider at

AVTX

Avalo Therapeutics, Inc. Healthcare

> 10% Shareholder

BBI

Brickell Biotech, Inc. Healthcare

> 10% Shareholder

KPRX

KIORA PHARMACEUTICALS INC Healthcare

> 10% Shareholder

SAVA

CASSAVA SCIENCES INC Healthcare

> 10% Shareholder

DFRG

Del Frisco's Restaurant Group, Inc.

> 10% Shareholder

VLRX

Valeritas Holdings Inc.

> 10% Shareholder

BPTH

BIO-PATH HOLDINGS INC Healthcare

> 10% Shareholder

AYTU

AYTU BIOPHARMA, INC Healthcare

Director

ACHV

ACHIEVE LIFE SCIENCES, INC. Healthcare

> 10% Shareholder

AMAG

AMAG PHARMACEUTICALS, INC.

> 10% Shareholder

RSLS

ReShape Weightloss Inc.

> 10% Shareholder

INNV

INNOVUS PHARMACEUTICALS, INC.

> 10% Shareholder

ONTX

Onconova Therapeutics, Inc. Healthcare

> 10% Shareholder

VXRT

Vaxart, Inc. Healthcare

Director

TTPH

TETRAPHASE PHARMACEUTICALS INC

Director

TENX

TENAX THERAPEUTICS, INC. Healthcare

Director

CYTH

Cyclo Therapeutics, Inc. Healthcare

> 10% Shareholder

RSLS

ReShape Lifesciences Inc. Healthcare

> 10% Shareholder

ACL